EGFR and non-small cell lung carcinoma: In another study, 30 patients with advanced EGFR/ALK wildtype NSCLC received ICI therapy and their plasma EVs were analyzed by whole transcriptome and small RNA sequencing followed by differential gene expression analysis [91].